Apollo Hospitals Enterprise Limited (BOM:508869)

BOM:508869 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	1,287,879	1,066,738	951,308	914,010	619,841	649,346
Market Cap Growth	20.23%	12.13%	4.08%	47.46%	-4.54%	55.58%
Enterprise Value	1,356,419	1,119,771	1,000,070	952,275	649,547	678,828
Last Close Price	8955.00	7428.40	6605.06	6316.72	4273.79	4460.67

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	66.33	54.94	65.79	101.72	75.67	61.51
PS Ratio	5.10	4.23	4.37	4.80	3.73	4.43
PB Ratio	12.91	10.70	10.99	12.49	9.49	11.00
P/TBV Ratio	15.69	13.00	13.80	15.79	12.14	14.19
P/FCF Ratio	144.11	119.36	224.52	116.67	249.53	62.51
P/OCF Ratio	45.10	37.35	44.53	47.60	45.02	38.29

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	5.38	4.44	4.59	5.00	3.91	4.63
EV/EBITDA Ratio	36.70	29.71	35.74	43.06	34.00	33.19
EV/EBIT Ratio	46.01	38.70	43.95	55.78	44.82	42.74
EV/FCF Ratio	151.78	125.30	236.03	121.56	261.49	65.35

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.85	0.85	0.91	0.73	0.66	0.69
Debt / EBITDA Ratio	2.25	2.25	2.65	2.27	2.14	1.89
Debt / FCF Ratio	9.50	9.50	18.56	6.81	17.44	3.92
Net Debt / Equity Ratio	0.64	0.64	0.68	0.57	0.55	0.51
Net Debt / EBITDA Ratio	1.69	1.69	2.09	1.87	1.89	1.48
Net Debt / FCF Ratio	7.12	7.12	13.82	5.29	14.52	2.91
Asset Turnover	1.18	1.18	1.17	1.22	1.20	1.19
Inventory Turnover	31.42	31.42	30.71	29.79	26.63	27.98
Quick Ratio	0.90	0.90	1.17	0.86	0.97	1.23
Current Ratio	1.07	1.07	1.54	1.13	1.30	1.67
Return on Equity (ROE)	21.50%	21.50%	18.84%	13.50%	13.58%	20.71%
Return on Assets (ROA)	8.44%	8.44%	7.60%	6.84%	6.54%	8.04%
Return on Invested Capital (ROIC)	14.17%	14.12%	12.94%	10.71%	11.67%	13.49%
Return on Capital Employed (ROCE)	18.40%	18.40%	14.20%	14.10%	13.10%	14.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.51%	1.82%	1.52%	0.98%	1.32%	1.63%
FCF Yield	0.69%	0.84%	0.45%	0.86%	0.40%	1.60%
Dividend Yield	0.22%	0.27%	0.29%	0.25%	0.35%	0.26%
Payout Ratio	14.81%	14.81%	18.89%	24.00%	31.16%	4.10%
Buyback Yield / Dilution	-0.08%	-0.08%	-	-	-	-2.71%
Total Shareholder Return	0.15%	0.19%	0.29%	0.25%	0.35%	-2.44%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error